Targeting of Endoplasmic Reticulum Dysfunction and Protein Folding Stress to Treat Neurological Conditions
Copyright © Targeted News Service 2024
2024-12-03
ALEXANDRIA, Virginia, Dec. 3 -- ALS THERAPY DEVELOPMENT INSTITUTE, Cambridge, Massachusetts has been assigned a patent (No. US 12157728 B2, initially filed June 23, 2023) developed by Alan Gill, Reading, Massachusetts, and Steven Perrin, Newbury, Massachusetts, for "Targeting of endoplasmic reticulum dysfunction and protein folding stress to treat neurological conditions." . . .